n-acetylmannosamine has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, TH; Chen, YB; Han, HY; Hsiao, M; Hsieh, CC; Li, WS; Liao, WY; Lin, PY; Lu, PC; Mao, WY; Shen, CN; Sher, YP; Shyr, YM; Wang, SE; Yang, WB | 1 |
1 other study(ies) available for n-acetylmannosamine and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructoseresponsive manner promotes pancreatic cancer metastasis.
Topics: Aged; Animals; Antigens, CD; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Dietary Sugars; Dose-Response Relationship, Drug; Female; Fructose; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, ras; Glucose Transporter Type 5; Hexosamines; Humans; Kaplan-Meier Estimate; Male; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Middle Aged; Neoplasm Invasiveness; Neoplasm Proteins; Pancreatic Neoplasms; Prognosis; RNA Interference; Sialyltransferases; Time Factors; Transfection; Up-Regulation | 2017 |